Interpace Biosciences, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2018
Total Assets: $31.1M
Liabilities Breakdown FY2018
Total Liabilities: $15.7M
Asset Breakdown
Total Assets: $31.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $6.1M | 19.5% |
| Accounts Receivable | $9.5M | 30.5% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $837.0K | 2.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $12.5M | 40.3% |
| Other Assets | $2.2M | 7.1% |
Liabilities Breakdown
Total Liabilities: $15.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.1M | 6.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $14.6M | 93.2% |